EBERT CHARLES D 4
4 · WATSON PHARMACEUTICALS INC · Filed Mar 1, 2012
Insider Transaction Report
Form 4
EBERT CHARLES D
Sr. VP, Research & Development
Transactions
- Sale
Common Stock, par value $0.0033
2012-02-29$58.77/sh−1,000$58,772→ 26,264 total - Sale
Common Stock, par value $0.0033
2012-02-29$58.81/sh−3,981$234,127→ 22,283 total - Exercise/Conversion
Incentive Stock Options to Purchase Common Stock
2012-02-29−1,000→ 0 totalExercise: $25.64From: 2010-09-01Exp: 2016-09-01→ Common Stock, par value $0.0033 (1,000 underlying) - Exercise/Conversion
Common Stock, par value $0.0033
2012-02-29$25.64/sh+1,000$25,640→ 27,264 total
Footnotes (1)
- [F1]Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.